Minerva Neurosciences, Inc. 2025 Annual Meeting of Stockholders Summary

Minerva Neurosciences, Inc. held its 2025 Annual Meeting of Stockholders on December 22, 2025. Key outcomes included the approval of an amendment to the 2013 Equity Incentive Plan to increase the authorized shares by 12,500,000. Stockholders also approved an amendment to the Certificate of Incorporation to increase the total authorized shares of Common Stock from 125,000,000 to 250,000,000. Additionally, the issuance of shares upon conversion of Series A Convertible Voting Preferred Stock was approved, along with the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Two directors, Fouzia Laghrissi-Thode and Inderjit Kaul, were elected. The compensation of named executive officers was also approved on an advisory basis.